oa Professional Nursing Today - In a new study RotarixTM offers 96% protection against severe rotavirus gastroenteritis and prevents 100% of rotavirus-associated hospitalizations : paediatrics

Volume 11, Issue 6
  • ISSN : 1607-6672



Data from a recent study announced at ESPID (European Society for Paediatric Infectious Diseases) shows that ROTARIXTM, the first oral rotavirus vaccine available to children in Europe, protects against 96% of severe rotavirus gastroenteritis (RVGE) cases and prevents 100% of hospitalisations due to rotavirusinduced gastroenteritis in a European setting.

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error